Assessmet of Patients With PAH Right Ventricular Volume
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)
- Status
- COMPLETED
- Phase
- PHASE2
Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- NA
Anastrozole in Patients With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- NA
Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan
- Status
- WITHDRAWN
- Phase
- PHASE4
Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
- Status
- COMPLETED
- Phase
- N/A
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
- Status
- TERMINATED
- Phase
- N/A
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
- Status
- COMPLETED
- Phase
- PHASE2
Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Pulmonary Perfusion Heterogeneity and Compliance in Patients With Pulmonary Hypertension Using Positron Emission Tomography Imaging
- Status
- COMPLETED
- Phase
- NA
A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor
- Status
- WITHDRAWN
- Phase
- PHASE3
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Apelin on the Lung Circulation in Pulmonary Hypertension
- Status
- UNKNOWN
- Phase
- NA
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
- Status
- COMPLETED
- Phase
- N/A
IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Oral Iron Supplementation in Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- NA
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
- Status
- COMPLETED
- Phase
- N/A